⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MPLT
MapLight Therapeutics Announces $150 Million Private Placement Financing
globenewswire.com
MPLT
MapLight Therapeutics, Inc. (MPLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Encourages MapLight Therapeutics, Inc. (MPLT) Shareholders to Inquire about Securities Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Is Investigating MapLight Therapeutics, Inc. (MPLT) And Encourages Shareholders to Connect
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against MapLight Therapeutics, Inc. (MPLT) And Encourages Shareholders to Reach Out
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against MapLight Therapeutics, Inc. (MPLT) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
MPLT
MapLight Therapeutics, Inc. (MPLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Is Investigating MapLight Therapeutics, Inc. (MPLT) And Encourages Investors to Connect
accessnewswire.com
MPLT